Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
EBIATShares Issued
Ratios

Terns Pharmaceuticals (TERN) Shares Outstanding (2020 - 2023)

Terns Pharmaceuticals' Shares Outstanding history spans 4 years, with the latest figure at $61.8 million for Q3 2023.

  • For Q3 2023, Shares Outstanding rose 64.26% year-over-year to $61.8 million; the TTM value through Sep 2023 reached $61.8 million, up 64.26%, while the annual FY2022 figure was $53.7 million, 112.6% up from the prior year.
  • Shares Outstanding reached $61.8 million in Q3 2023 per TERN's latest filing, up from $61.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $61.8 million in Q3 2023 to a low of $215890.0 in Q1 2020.
  • Average Shares Outstanding over 4 years is $28.2 million, with a median of $25.3 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: surged 11499.3% in 2021, then rose 0.91% in 2022.
  • A 4-year view of Shares Outstanding shows it stood at $337508.0 in 2020, then soared by 7387.01% to $25.3 million in 2021, then skyrocketed by 112.6% to $53.7 million in 2022, then grew by 15.01% to $61.8 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Shares Outstanding are $61.8 million (Q3 2023), $61.1 million (Q2 2023), and $56.7 million (Q1 2023).